Table 3. Prevalence Ratios for Smoking from Univariate and Multivariate Analysis among HIV-seropositive Participants.

	Univariate Analysis		Multivariate Analysis
	HIV-seropositive	p-value	HIV-seropositive	p-value
Age	0.996 (.995-.997)	<0.0001	0.999 (.0996-1.00)	0.35
Race
White, non-Hispanic	Reference	-	Reference	-
Black, non-Hispanic	1.10 (1.06-1.13)	<0.0001	1.05 (0.99-1.12)	0.094
Other	1.01 (0.97-1.04)	0.6986	0.94 (0.87-1.02)	0.133
Education
High School Diploma or Less	1.23 (1.19-1.27)	<0.0001	1.18 (1.10-1.27)	<0.0001
Some College or College Degree	1.10 (1.07-1.13)	<0.0001	1.07 (1.02-1.12)	0.007
Graduate Work or More	Reference		Reference
Enrolled after 2001	1.13 (1.08-1.18)	<0.0001	1.13 (1.06-1.21)	0.0004
Unemployed	1.11 (1.08-1.13)	<0.0001	1.05 (0.99-1.10)	0.109
Site
Baltimore/Washington DC	Reference	-	-	-
Chicago	1.03 (0.99-1.07)	0.134	-	-
Los Angeles	1.00 (0.97-1.03)	0.962	-	-
Pittsburgh	1.04 (0.99-1.08)	0.081	-	-
Alcohol use
None	Reference	-	Reference	-
Low - Moderate	1.11 (1.07-1.15)	<0.0001	1.07 (1.03-1.12)	0.0003
Moderate – Heavy	1.13 (1.06-1.20)	<0.0001	1.08 (0.99-1.16)	0.069
Binge	1.22 (1.16-1.28)	0.0001	1.14 (1.08-1.21)	<0.0001
Marijuana use	1.11 (1.09-1.14)	<0.0001	1.09 (1.05-1.13)	<0.0001
Hospitalization in the last 6 months	1.02 (1.01-1.04)	0.0013	1.02 (0.99-1.04)	0.234
Depressed Symptoms	1.07 (1.05-1.09)	<0.0001	1.02 (1.01-1.04)	0.001
CD4+ T-cell count (cells/μl)
>500	Reference	-	-	-
201-500	1.00 (.99-1.02)	0.643	-	-
≤ 200	1.02 (0.99-1.04)	0.101	-	-
HAART Use
No Therapy	1.04 (1.02-1.06)	<0.0001	1.00 (0.96-1.03)	0.885
Monotherapy	1.01 (0.99-1.03)	0.421	1.01 (.93-1.10)	0.806
Combined Therapy	0.99 (0.96-1.01)	0.309	1.03 (0.96-1.10)	0.425
Potent ART	Reference	-	Reference	-
Detectable Viral Load	1.06 (1.04-1.08)	<0.0001	1.04 (1.02-1.06)	<0.0001